Abbott Laboratories and Johnson & Johnson separately reported recoveries from elective procedures earlier than expected in US hospitals in the second quarter, even as the nation struggles with an increasingly severe COVID-19 pandemic. Shares of Abbott ABT, + 2.95% closed at a year-to-date high of $ 99.25, the day after …
Read More »Abbott, J&J results were fueled by June’s surprising surge in medical procedures, even as coronavirus cases rise
